LGND Ligand Pharmaceuticals Incorporated

NASDAQ

$295.54

Ligand Pharmaceuticals Incorporated (LGND) Earnings News

Earnings press releases, previews and reviews for Ligand Pharmaceuticals Incorporated (LGND), newest first.

Thursday October 15, 2026 7:00 AM ET

Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026

Thursday August 6, 2026 7:00 AM ET

Ligand Reports Second Quarter 2026 Financial Results

Thursday July 23, 2026 7:00 AM ET

Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026

Tuesday July 14, 2026 9:00 AM ET

Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets

Wednesday June 10, 2026 7:00 AM ET

Ligand Announces 2026 Investor Day in New York City

Thursday May 7, 2026 7:00 AM ET

Ligand Reports First Quarter 2026 Financial Results

Monday April 27, 2026 7:00 AM ET

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

Wednesday April 22, 2026 7:00 AM ET

Ligand to Report First Quarter 2026 Financial Results on May 7, 2026